Literature DB >> 21358870

Epidermodysplasia verruciformis: An early and unusual presentation.

Ilteris Murat Emsen1, M Esref Kabalar.   

Abstract

Epidermodysplasia verruciformis is a rare, heritable disease characterized by an unusual susceptibility to infection with specific types of human papillomavirus and a propensity for developing malignant skin tumours. Partial defects in cell-mediated immunity have been demonstrated in this disease. In the present report, a young patient with epidermodysplasia verruciformis who was treated successfully with surgical treatment is described.

Entities:  

Keywords:  Cell-mediated immunity; Epidermodysplasia verruciformis; Human papillomavirus

Year:  2010        PMID： 21358870      PMCID： PMC2851455     

Source DB:  PubMed          Journal:  Can J Plast Surg        ISSN： 1195-2199


  9 in total

1.  The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis.

Authors:  Walmar R P de Oliveira; Cyro Festa Neto; Evandro A Rivitti
Journal:  J Am Acad Dermatol       Date:  2004-06       Impact factor: 11.527

2.  Dermoscopy in epidermodysplasia verruciformis.

Authors:  Sonia Segura; Cristina Carrera; Juan Ferrando; José Manuel Mascaró; Josep Palou; Josep Malvehy; Susana Puig
Journal:  Dermatol Surg       Date:  2006-01       Impact factor: 3.398

3.  Epidermodysplasia verruciformis in two brothers developing aggressive squamous cell carcinoma.

Authors:  Inja Bogdan; Leo Schärer; René Rüdlinger; Jürg Hafner
Journal:  Dermatol Surg       Date:  2007-12       Impact factor: 3.398

4.  Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.

Authors:  R Anadolu; T Oskay; C Erdem; A Boyvat; E Terzi; E Gürgey
Journal:  J Am Acad Dermatol       Date:  2001-08       Impact factor: 11.527

5.  Epidermodysplasia verruciformis in two half brothers with HIV infection.

Authors:  Weimin Hu; Gerard Nuovo; Marlene Willen; Stephen Somach
Journal:  J Cutan Med Surg       Date:  2004 Sep-Oct       Impact factor: 2.092

6.  Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25.

Authors:  N Ramoz; A Taïeb; L A Rueda; L S Montoya; B Bouadjar; M Favre; G Orth
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

7.  Epidermodysplasia verruciformis: an unusual presentation.

Authors:  Turgut Ortak; Ahmet Cagri Uysal; Murat Sahin Alagoz; Hakan Orbay; Omer Sensoz
Journal:  Dermatol Surg       Date:  2006-02       Impact factor: 3.398

Review 8.  Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.

Authors:  S Majewski; S Jabłońska
Journal:  Arch Dermatol       Date:  1995-11

9.  Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.

Authors:  Cindy Berthelot; Mary C Dickerson; Peter Rady; Qin He; Farhad Niroomand; Stephen K Tyring; Amit G Pandya
Journal:  J Am Acad Dermatol       Date:  2007-03-26       Impact factor: 11.527
  9 in total
  2 in total

Review 1.  Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation.

Authors:  Dalton Dacus; Nicholas A Wallace
Journal:  Viruses       Date:  2021-08-21       Impact factor: 5.048

2.  Histopathological Study of Verrucous Lesions and its Mimics.

Authors:  Kriti Chauhan; Vikram Jassal; Gazalpreet Kaur Sara; Vijay Bansal; Varun Hatwal
Journal:  J Microsc Ultrastruct       Date:  2021-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.